MedTrace Logo

Validation and Reliability of the CHO-KLAT in Turkish

NCT05439642 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-06-30

No results posted yet for this study

Summary

The aim of this study is to investigate the Turkish validity and reliability of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool version2.0. Patients aged 4-18 years with hemophilia a or b will be included in the study. The study was planned as a multicenter and it is aimed to reach 100 patients. The process included four steps: a linguistic adaptation, cognitive debriefing interviews with children and their parents, a validity assessment with the Pediatric Quality of Life Inventory (PedsQL) as a comparator, and a test retest reliability assessment.

Conditions

Interventions

OTHER

Evaluation of health related quality of life

Evaluation of health related quality of life of boys with hemophilia with the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool and the Pediatric Inventory of Quality of Life

Sponsors & Collaborators

  • Hasan Kalyoncu University

    collaborator OTHER

  • University of Gaziantep

    collaborator OTHER

  • Acıbadem Adana Hospital

    collaborator OTHER

  • Yuzuncu Yıl University

    lead OTHER

Principal Investigators

  • Ayse Merve Tat, Asst.Prof · Van Yuzuncu Yıl University Faculty of Health Sciences

  • Tugba Badat Gonen, PhD · Hasan Kalyoncu University Faculty Of Health Sciences

  • Ahmet Fayik Oner, Prof MD · Van Yuzuncu Yıl University Faculty of Medicine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2022-09-01
Completion
2022-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05439642 on ClinicalTrials.gov